US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 0.900
  • +0.020+2.28%
Close May 31 16:00 ET
48.88MMarket Cap-1525P/E (TTM)

Cytosorbents Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
-26.80%29.36M
-21.20%7.64M
-27.40%6.46M
-35.50%7.33M
Operating revenue
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
-26.80%29.36M
-21.20%7.64M
-27.40%6.46M
-35.50%7.33M
Cost of revenue
-19.49%3.22M
0.01%13.96M
-7.61%3.36M
-28.70%3.2M
-4.18%3.4M
75.36%3.99M
26.33%13.96M
16.35%3.63M
82.46%4.49M
31.01%3.55M
Gross profit
47.45%5.77M
11.19%17.13M
-0.42%3.99M
131.12%4.55M
23.55%4.67M
-30.65%3.92M
-46.99%15.4M
-39.03%4.01M
-69.42%1.97M
-56.33%3.78M
Operating expense
-9.39%10.7M
3.01%48.34M
28.64%13.33M
8.32%11.9M
-7.48%11.23M
-12.13%11.81M
-9.42%46.93M
-35.77%10.36M
-7.25%10.99M
-10.63%12.14M
Selling and administrative expenses
1.26%9.25M
1.98%37.87M
21.18%10.56M
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
-3.50%37.14M
-21.40%8.71M
10.70%9.34M
-13.48%9.12M
-General and administrative expense
1.26%9.25M
1.98%37.87M
21.18%10.56M
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
-3.50%37.14M
-21.40%8.71M
10.70%9.34M
-13.48%9.12M
Research and development costs
-46.65%2.25M
4.03%15.73M
20.42%4.1M
13.95%3.75M
-12.30%3.67M
-0.68%4.21M
-7.70%15.12M
-44.57%3.4M
-22.81%3.29M
13.09%4.18M
Other operating expenses
48.24%-796.77K
1.21%-5.26M
24.52%-1.32M
35.90%-1.06M
-15.76%-1.35M
-100.72%-1.54M
-74.32%-5.33M
-61.25%-1.75M
-92.03%-1.65M
-76.86%-1.16M
Operating profit
37.59%-4.93M
0.99%-31.21M
-46.96%-9.34M
18.49%-7.35M
21.51%-6.56M
-1.29%-7.89M
-38.59%-31.52M
33.52%-6.36M
-66.80%-9.02M
-69.70%-8.36M
Net non-operating interest income expense
89.47%-6.65K
-219.08%-157.89K
-197.17%-52.23K
-171.88%-33.67K
-136.80%-8.82K
-886.97%-63.17K
373.44%132.6K
337.19%53.75K
266.95%46.85K
83.39%23.97K
Total other finance cost
-89.47%6.65K
219.08%157.89K
197.17%52.23K
171.88%33.67K
136.80%8.82K
886.97%63.17K
-373.44%-132.6K
-337.19%-53.75K
-266.95%-46.85K
---23.97K
Other net income (expense)
-326.70%-1.43M
181.32%2.05M
-38.23%2.75M
43.98%-1.81M
116.30%414.97K
153.15%628.88K
2.41%-2.52M
1,000.51%4.44M
-218.87%-3.23M
-1,187.49%-2.55M
Gain on sale of security
-315.79%-1.43M
179.61%1.95M
-40.61%2.68M
43.98%-1.81M
116.45%414.97K
154.45%660.68K
5.02%-2.45M
1,015.53%4.52M
-218.87%-3.23M
-1,177.60%-2.52M
Other non- operating income (expenses)
----
243.76%96.75K
183.30%61.75K
----
----
-205.99%-31.8K
---67.3K
---74.13K
---29
---23.14K
Income before tax
13.21%-6.36M
13.52%-29.32M
-257.70%-6.65M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-34.04%-33.91M
81.49%-1.86M
-90.45%-12.2M
-132.58%-10.88M
Income tax
0
25.52%-813.74K
25.52%-813.74K
0
0
0
-48.45%-1.09M
-48.45%-1.09M
0
0
Net income
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
-132.58%-10.88M
Net income continuous Operations
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
-132.58%-10.88M
Minority interest income
Net income attributable to the parent company
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
-132.58%-10.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
-132.58%-10.88M
Basic earnings per share
29.41%-0.12
14.67%-0.64
-1,100.00%-0.12
25.00%-0.21
44.00%-0.14
19.05%-0.17
-31.58%-0.75
95.24%-0.01
-86.67%-0.28
-127.27%-0.25
Diluted earnings per share
29.41%-0.12
14.67%-0.64
-1,100.00%-0.12
25.00%-0.21
44.00%-0.14
19.05%-0.17
-31.58%-0.75
95.24%-0.01
-86.67%-0.28
-127.27%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M-26.80%29.36M-21.20%7.64M-27.40%6.46M-35.50%7.33M
Operating revenue 13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M-26.80%29.36M-21.20%7.64M-27.40%6.46M-35.50%7.33M
Cost of revenue -19.49%3.22M0.01%13.96M-7.61%3.36M-28.70%3.2M-4.18%3.4M75.36%3.99M26.33%13.96M16.35%3.63M82.46%4.49M31.01%3.55M
Gross profit 47.45%5.77M11.19%17.13M-0.42%3.99M131.12%4.55M23.55%4.67M-30.65%3.92M-46.99%15.4M-39.03%4.01M-69.42%1.97M-56.33%3.78M
Operating expense -9.39%10.7M3.01%48.34M28.64%13.33M8.32%11.9M-7.48%11.23M-12.13%11.81M-9.42%46.93M-35.77%10.36M-7.25%10.99M-10.63%12.14M
Selling and administrative expenses 1.26%9.25M1.98%37.87M21.18%10.56M-1.46%9.21M-2.30%8.91M-8.32%9.13M-3.50%37.14M-21.40%8.71M10.70%9.34M-13.48%9.12M
-General and administrative expense 1.26%9.25M1.98%37.87M21.18%10.56M-1.46%9.21M-2.30%8.91M-8.32%9.13M-3.50%37.14M-21.40%8.71M10.70%9.34M-13.48%9.12M
Research and development costs -46.65%2.25M4.03%15.73M20.42%4.1M13.95%3.75M-12.30%3.67M-0.68%4.21M-7.70%15.12M-44.57%3.4M-22.81%3.29M13.09%4.18M
Other operating expenses 48.24%-796.77K1.21%-5.26M24.52%-1.32M35.90%-1.06M-15.76%-1.35M-100.72%-1.54M-74.32%-5.33M-61.25%-1.75M-92.03%-1.65M-76.86%-1.16M
Operating profit 37.59%-4.93M0.99%-31.21M-46.96%-9.34M18.49%-7.35M21.51%-6.56M-1.29%-7.89M-38.59%-31.52M33.52%-6.36M-66.80%-9.02M-69.70%-8.36M
Net non-operating interest income expense 89.47%-6.65K-219.08%-157.89K-197.17%-52.23K-171.88%-33.67K-136.80%-8.82K-886.97%-63.17K373.44%132.6K337.19%53.75K266.95%46.85K83.39%23.97K
Total other finance cost -89.47%6.65K219.08%157.89K197.17%52.23K171.88%33.67K136.80%8.82K886.97%63.17K-373.44%-132.6K-337.19%-53.75K-266.95%-46.85K---23.97K
Other net income (expense) -326.70%-1.43M181.32%2.05M-38.23%2.75M43.98%-1.81M116.30%414.97K153.15%628.88K2.41%-2.52M1,000.51%4.44M-218.87%-3.23M-1,187.49%-2.55M
Gain on sale of security -315.79%-1.43M179.61%1.95M-40.61%2.68M43.98%-1.81M116.45%414.97K154.45%660.68K5.02%-2.45M1,015.53%4.52M-218.87%-3.23M-1,177.60%-2.52M
Other non- operating income (expenses) ----243.76%96.75K183.30%61.75K---------205.99%-31.8K---67.3K---74.13K---29---23.14K
Income before tax 13.21%-6.36M13.52%-29.32M-257.70%-6.65M24.65%-9.19M43.44%-6.15M18.30%-7.33M-34.04%-33.91M81.49%-1.86M-90.45%-12.2M-132.58%-10.88M
Income tax 025.52%-813.74K25.52%-813.74K000-48.45%-1.09M-48.45%-1.09M00
Net income 13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M-132.58%-10.88M
Net income continuous Operations 13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M-132.58%-10.88M
Minority interest income
Net income attributable to the parent company 13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M-132.58%-10.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M-132.58%-10.88M
Basic earnings per share 29.41%-0.1214.67%-0.64-1,100.00%-0.1225.00%-0.2144.00%-0.1419.05%-0.17-31.58%-0.7595.24%-0.01-86.67%-0.28-127.27%-0.25
Diluted earnings per share 29.41%-0.1214.67%-0.64-1,100.00%-0.1225.00%-0.2144.00%-0.1419.05%-0.17-31.58%-0.7595.24%-0.01-86.67%-0.28-127.27%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg